Metrodora Therapeutics Revenue

Biotechnology Research • United States • 1-10 Employees

Metrodora Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Metrodora Therapeutics

Zefi Athanasiou

Director of Regulatory Affairs and Quality

Company overview

Headquarters	United States
Website	metrodora.com
SIC	873
Keywords	Pregnancy, Women'S Health, Maternal Fetal Medicine
Employees	1-10

Metrodora Therapeutics Email Formats

Metrodora Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@metrodora.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@metrodora.com	100%

About Metrodora Therapeutics

Metrodora Therapeutics is dedicated to treating inflammation, infection and microbiome dysregulation. Our specialty focus thereby includes a commitment to serving the health and medical needs of people throughout their lives, and particularly so during vulnerable stages such as pregnancy, preterm birth and old age. Because the well-being of our patients is the core element of our mission, we consciously and routinely foster a patient-centric culture. Our culture is biased toward action, with an unbending commitment to service and excellence through innovation.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Metrodora Therapeutics has never raised funding before.

Metrodora Therapeutics Tech Stack

Discover the technologies and tools that power Metrodora Therapeutics's digital infrastructure, from frameworks to analytics platforms.

GoDaddy

Hosting

Nginx

Reverse proxies

OpenResty

Web servers

Frequently asked questions

Metrodora Therapeutics is located in US.

Metrodora Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Metrodora Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Metrodora Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Metrodora Therapeutics

Zefi Athanasiou

Director of Regulatory Affairs and Quality

4.8

40,000 users